Edge Pharma, LLC recalls PHENYLephrine, 0.9% Sodium Chloride Injection, USP, 20 mg/250mL, (0.08 mg/mL), Single use bag for IV injection (Preserva
Recalled February 2, 2022 · FDA recall D-0418-2022 · Edge Pharma
Hazard
Lack of Assurance of Sterility · FDA Class II
Units
3930 bags
Sold at
nationwide
Description
Lack of Assurance of Sterility
Product
PHENYLephrine, 0.9% Sodium Chloride Injection, USP, 20 mg/250mL, (0.08 mg/mL), Single use bag for IV injection (Preservative Free), Rx Only, Edge Pharma, LLC, 856 Hercules Dr, Colchester, VT NDC 05446-1667-01
Manufacturer(s)
Edge Pharma, LLC
Source: U.S. Food and Drug Administration. Official recall notice on fda.gov →